Sign In
Buy QDEL
$13.60
+0.310 (+2.33%)
At Close: Jun 03, 2026
QuidelOrtho: Attractive Valuation Despite Weak Performance
12:38pm, Saturday, 13'th Apr 2024
QuidelOrtho's profitability has been impacted by higher depreciation and non-operating expenses, but improvements in gross margins and reduced expenses are expected in 2024. The company's revenue grow
QuidelOrtho's (QDEL) New Test to Offer Enhanced Opioid Testing
12:51pm, Friday, 12'th Apr 2024
QuidelOrtho's (QDEL) addition of the Fentanyl Test is likely to deliver rapid drugs-of-abuse detection amidst the escalating opioid crisis.
QuidelOrtho's (QDEL) QuickVue Gets FDA Nod for COVID Testing
11:51am, Wednesday, 03'rd Apr 2024
QuidelOrtho (QDEL) announces the FDA's approval of QuickVue, which is likely to be used for convenient and accurate COVID-19 pathogen testing.
QuidelOrtho's (QDEL) New Approval to Aid Pre-eclampsia Diagnosis
11:46am, Thursday, 07'th Mar 2024
QuidelOrtho's (QDEL) receipt of Health Canada's approval is likely to aid in the diagnosis of preterm pre-eclampsia and prognosis of delivery in symptomatic women.
QuidelOrtho to Participate in 45th Annual Raymond James Institutional Investor Conference
04:30pm, Monday, 26'th Feb 2024
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical l
Why QuidelOrtho Stock Is Crashing Today
12:27pm, Wednesday, 14'th Feb 2024
QuidelOrtho's fourth-quarter revenue and earnings fell year over year. The company provided disappointing full-year 2024 guidance.
QuidelOrtho (QDEL) Q4 Earnings and Sales Miss, Margins Fall
11:06am, Wednesday, 14'th Feb 2024
Despite solid performances by the Labs segment and China and Other regions, QuidelOrtho (QDEL) misses earnings and revenue estimates by 41.8% and 6.9%, respectively.
QuidelOrtho stock drops 33% on earnings miss
09:20am, Wednesday, 14'th Feb 2024
QuidelOrtho Corp.'s stock QDEL was down 33% in premarket trading on volume of 436,000 on Wednesday after the diagnostic products manufacturer missed its fourth-quarter profit and revenue estimates. Th
QuidelOrtho Corporation (QDEL) Q4 2023 Earnings Call Transcript
09:09pm, Tuesday, 13'th Feb 2024
QuidelOrtho Corporation (QDEL) Q4 2023 Earnings Call Transcript
QuidelOrtho (QDEL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
08:31pm, Tuesday, 13'th Feb 2024
Although the revenue and EPS for QuidelOrtho (QDEL) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall
QuidelOrtho (QDEL) Misses Q4 Earnings and Revenue Estimates
06:31pm, Tuesday, 13'th Feb 2024
QuidelOrtho (QDEL) came out with quarterly earnings of $1.17 per share, missing the Zacks Consensus Estimate of $2.02 per share. This compares to earnings of $1.76 per share a year ago.
This stock fund manager outperforms with ‘fixer-uppers'
01:45pm, Tuesday, 16'th Jan 2024
Small-cap stocks can help investors diversify from the S&P 500, which is heavily weighted to the largest U.S. tech players. Investors may imagine small-caps as up-and-coming companies focused on incre
QuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare Conference
07:00am, Friday, 22'nd Dec 2023
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (NASDAQ:QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical l
QuidelOrtho's (QDEL) Latest FDA Nod to Boost Diagnostic Testing
12:47pm, Thursday, 21'st Dec 2023
QuidelOrtho's (QDEL) receipt of the FDA's latest approval is likely to improve clinical care, provide cost savings and deliver sample-to-result molecular testing across all laboratory settings.
Here's Why You Should Retain QuidelOrtho (QDEL) Stock for Now
11:18am, Tuesday, 19'th Dec 2023
QuidelOrtho's (QDEL) strong product portfolio raises optimism about the stock.
